Company Overview and News
Nyrstar NV ("Nyrstar" or the "Company") notes the comments made by the Treasurer of South Australia, the Hon. Rob Lucas MLC, to the Legislative Council of the South Australian Parliament on Thursday, 17 May 2018 in relation to the timing of the payment of the Perpetual Securities for the Port Pirie Redevelopment (the "Project").
Nyrstar NV ("Nyrstar" of de "Vennootschap") neemt akte van de opmerkingen die op 17 mei 2018 door de Treasurer of South Australia, Hon. Rob Lucas MLC, werden gericht aan de Legislative Council van het South Australian Parliament met betrekking tot de timing van de betaling van de Perpetual Securities (eeuwigdurende effecten) voor de Port Pirie Herontwikkeling (het "Project").
ROUYN-NORANDA, Québec, April 25, 2018 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (TSX:GMX) (FRANCFORT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) is pleased to provide shareholders with a short update regarding our Middle Tennessee Mines Royalty.
Nyrstar NV (the "Company") held its annual general shareholders' meeting ("AGM") as well as an extraordinary general shareholders' meeting ("EGM") in Brussels today.
Nyrstar NV (de "Vennootschap") hield vandaag in Brussel haar gewone algemene aandeelhoudersvergadering ("GAV") en een buitengewone algemene aandeelhoudersvergadering ("BAV").
Nyrstar NV (de "Vennootschap") kondigt aan dat zij vandaag 839.456 nieuwe gewone aandelen heeft uitgegeven middels een kapitaalverhoging in geld voor een bedrag van EUR 4.793.293,76 (bestaande uit kapitaal en uitgiftepremie) in het kader van het toegestaan kapitaal. Op de nieuwe aandelen werd ingeschreven door bepaalde bestaande personeelsleden van de Vennootschap en haar dochtervennootschappen die ervoor hebben geopteerd om het netto-cash equivalent in euro (EUR) van hun award voor het prestatiejaar 2017 onder het Annual Incentive Plan van de Vennootschap aan te wenden om in te schrijven op nieuwe aandelen van de Vennootschap.
Nyrstar NV (the "Company") announces that today it has issued 839,456 new ordinary shares in a capital increase in cash for an amount of EUR 4,793,293.76 (consisting of capital and issue premium) within the framework of the authorised capital. The new shares were subscribed for by certain existing employees of the Company and its subsidiaries that elected to use the net-cash equivalent of their award for performance year 2017 under the Company's Annual Incentive Plan to subscribe for new shares in the Company.
The following slide deck was published by Nyrstar NV in conjunction with their 2017 Q4 earnings call.
Ironbark Zinc Limited (ASX:IBG) has appointed Kelly Strong, a nominee of Nyrstar NV (EBR:NYR), one of the world’s largest zinc metal producers, as non-executive director.
Thank you, operator. Good morning everyone and welcome to Nyrstar's Q3 2017 Results presentation. On this morning call; I am joined by Hilmar Rode; our CEO, and also Chris Eger, our CFO. As usual, we will do a presentation; we will run through results in the last nine months, we will follow that with a Q&A session.
Good morning everyone and welcome to Nyrstar's First Half 2017 Results presentation. My name is Anthony Simms, and I’m the Head of Investor Relations at Nyrstar. Joining me on the today’s call is Hilmar Rode; our Chief Executive Officer, and Chris Eger, our Chief Financial Officer. Today’s presentation will be filled, will be followed rather by a question-and-answer session.
TORONTO, ONTARIO--(Marketwired - Aug. 2, 2017) - Asian Mineral Resources Limited ("AMR" or the "Company") (TSX VENTURE:ASN), which owns the Ban Phuc nickel mine in Vietnam, is pleased to announce the appointment of Kate Southwell to the Board of Directors, replacing Martyn Buttenshaw who will resign from the board, effective August 2, 2017.
The following slide deck was published by Nyrstar NV in conjunction with their 2017 Q2 earnings call.
ROUYN-NORANDA, QUÉBEC--(Marketwired - July 24, 2017) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to inform shareholders that the Nyrstar NV, Mid Tennessee mine and mill complex has been in operation since May 2017 and is rapidly increasing production to full capacity.
ROUYN-NORANDA, QUEBEC--(Marketwired - June 20, 2017) - GLOBEX MINING ENTERPRISES INC. (TSX:GMX)(FRANKFURT:G1MN)(STUTTGART:G1MN)(BERLIN:G1MN)(MUNICH:G1MN)(XETRA:G1MN)(OTCQX:GLBXF) is pleased to update shareholders regarding various optioned and royalty projects.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...